Scarica l'app Stockscreener
0.79
2.75%
-0.0223
Dopo l'orario di chiusura:
.79
Precedente Chiudi:
$0.8123
Aprire:
$0.8259
Volume 24 ore:
52,868
Relative Volume:
0.42
Capitalizzazione di mercato:
$9.20M
Reddito:
$39.19M
Utile/perdita netta:
$-16.59M
Rapporto P/E:
-0.3621
EPS:
-2.182
Flusso di cassa netto:
$-9.39M
1 W Prestazione:
-4.04%
1M Prestazione:
-3.39%
6M Prestazione:
+19.88%
1 anno Prestazione:
-25.47%
Intervallo 1D:
$0.79
$0.8259
Intervallo di 1 settimana:
$0.77
$0.8351
Portata 52W:
$0.536
$1.87
Biofrontera Inc Stock (BFRI) Company Profile
Nome
Biofrontera Inc
Settore
Telefono
781-245-1325
Indirizzo
120 PRESIDENTIAL WAY,, WOBURN
Confronta BFRI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BFRI
Biofrontera Inc
|
0.79 | 9.46M | 39.19M | -16.59M | -9.39M | -2.182 |
|
ZTS
Zoetis Inc
|
120.98 | 52.29B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.61 | 45.27B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.83 | 42.39B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.13 | 34.18B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
500.30 | 21.27B | 3.08B | 1.24B | 1.07B | 25.61 |
Biofrontera Inc Borsa (BFRI) Ultime notizie
Aug Levels: Will Biofrontera Inc Equity Warrant stock split attract more investorsPortfolio Performance Summary & AI Enhanced Trading Alerts - moha.gov.vn
What analysts say about Biofrontera Inc AI10 stockContrarian Investment Ideas & Free Daily Top Stock Picks for All Investors - earlytimes.in
Biofrontera (NASDAQ:BFRI) Trading Down 1.5% – Time to Sell? - Defense World
Biofrontera Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Biofrontera completes phase 1 study for expanded Ameluz treatment areas By Investing.com - Investing.com Nigeria
Will Biofrontera Inc. (AI10) stock sustain bullish trend into 2025Market Growth Review & Risk Controlled Swing Alerts - Newser
Why Biofrontera Inc. (AI10) stock attracts HNW investors2025 Big Picture & Safe Entry Momentum Tips - Newser
Why Biofrontera Inc. (AI10) stock is favored by hedge fundsWeekly Trade Analysis & Daily Oversold Stock Bounce Ideas - Newser
Will Biofrontera Inc. Equity Warrant stock outperform growth indexes2025 Investor Takeaways & Risk Controlled Stock Pick Alerts - Newser
Biofrontera completes final patient visit in Phase 1 PK study of Ameluz gel - TipRanks
Biofrontera completes phase 1 study for expanded Ameluz treatment areas - Investing.com
Last Patient Completes Biofrontera’s Phase 1 Pharmacokinetics Study of Ameluz® for Treatment of Actinic Keratoses on the Trunk and Extremities - GlobeNewswire
Biofrontera files sNDA for Ameluz-PDT in treatment of sBCC - MSN
Can Biofrontera Inc. (AI10) stock survive global slowdownJuly 2025 Update & High Yield Stock Recommendations - Newser
Why Biofrontera Inc. stock remains on buy listsWatch List & Long Hold Capital Preservation Plans - Newser
Biofrontera Inc. (BFRI) 5.8% in After-hours: Filing for New Drug Application Boosts Stock - Stocks Telegraph
Biofrontera submits sNDA to FDA for skin cancer treatment By Investing.com - Investing.com Australia
Biofrontera Inc. (BFRI) 20.51% in After-hours: Notable Price Surge - Stocks Telegraph
Biofrontera submits sNDA to FDA for skin cancer treatment - Investing.com
Biofrontera Inc. announces filing of supplemental new drug application - marketscreener.com
Biofrontera Inc. Announces Filing of Supplemental New Drug Application (sNDA) for the Treatment of Superficial Basal Cell Carcinoma (sBCC) with Ameluz®-PDT - The Manila Times
Why global investors buy Biofrontera Inc. (AI10) stockJuly 2025 Selloffs & AI Enhanced Trading Alerts - Newser
Biofrontera (BFRI) Stock Analysis Report | Financials & Insights - Benzinga
What analysts say about Biofrontera Inc Equity Warrant stockVWAP Trading Strategies & Small Budget Trading Portfolio - earlytimes.in
PTA-News: Biofrontera AG: BIOFRONTERA REPORTS RESULTS FOR THE FIRST NINE MONTHS OF 2025 - TradingView — Track All Markets
BIOFRONTERA REPORTS RESULTS FOR THE FIRST NINE MONTHS OF 2025 - TradingView
Biofrontera, Inc. Navigates Mixed Earnings Call - MSN
Biofrontera reports Q3 EPS (62c) vs (98c) last year - MSN
Is Biofrontera Inc. stock a top momentum playJuly 2025 Macro Moves & Growth Focused Stock Reports - BỘ NỘI VỤ
Its Stock Has Paid Off Big Time For Biofrontera Inc - Setenews
Is Biofrontera Inc a good long term investmentInsider Buying Signals & Lower Drawdowns With Smart Position Sizing - earlytimes.in
How interest rate cuts could boost Biofrontera Inc. Equity Warrant stock - BỘ NỘI VỤ
Is National Plywood Industries Limiteds Business Model Sustainable Long TermMarket Capitalization Trends & Receive Monthly Expert Trading Blueprints - earlytimes.in
How reliable is Biofrontera Inc. (AI10) stock dividend growthEarnings Growth Summary & Weekly Chart Analysis and Guides - newser.com
Why Biofrontera Inc. Equity Warrant is moving todayJuly 2025 Decliners & Community Trade Idea Sharing Platform - newser.com
Why Biofrontera Inc. (AI10) stock could outperform next yearJuly 2025 Gainers & Consistent Income Trade Ideas - newser.com
News impact scoring models applied to Biofrontera Inc.Weekly Trade Summary & Weekly Hot Stock Watchlists - newser.com
Will Biofrontera Inc. (AI10) stock benefit from commodity supercycleGDP Growth & Safe Entry Trade Reports - newser.com
Biofrontera Inc Azioni (BFRI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.98%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):